===
EQS Voting Rights Announcement: BB BIOTECH AG
BB BIOTECH AG: Disclosure of Shareholdings
2024-05-10 / 17:40 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Disclosure of Shareholdings
Published, 08/05/2024

Notification ID: 95e58c52-be79-4dff-913a-3d312fe9da73

Notification of Collective Investment Schemes
PART 1: LICENSEE
Company name and head office of the licensee resp. for foreign collective investment schemes, which are not authorized
for sale and are not dependent from a group of companies, company name and head office of the fund administration or
the investment company:
Company: UBS Fund Management (Switzerland) A
City: Basel
Country: Switzerland

PART 2: COLLECTIVE INVESTMENT SCHEME/S
Name of collective investment scheme/s which hold/s individually 3% or more voting rights

PART 3: DATE AND REASON FOR THE REPORTING OBLIGATION
Date of the act that creates the obligation to notify: 30.04.2024
Date of transfer of equity securities (if different from date of the act which
creates the obligation to notify):

Facts and circumstances triggering the obligation to notify (art. 22 para. 1 b FMIO-FINMA):
Acquisition
Sale
Creation of a group
Change in group composition Termination of a group
Discretionary exercise of voting rights
Securities lending and comparable transactions
Exercise, non-exercise or expiration of derivative holdings
Granting (writing) of derivative holdings
Capital increase
Capital reduction
Ipso jure transfer or transfer due to a decision by a court or public authority
Change in the information subject to the obligation to notify
Other X
Disclosure triggered due to the absorption merger ("Absorptionsfusion") between Credit Suisse Funds AG and UBS Fund
Management (Switzerland) AG and the aggregation of the relevant interest of both entities as upon merger Credit Suisse
Funds AG ceased to exist and UBS Fund Management (Switzerland) AG was the surviving entity.
Total of voting rights below 3%
If the participation falls below the threshold of 3% (purchase positions and sale positions), no indication in Part 4
or Part 5 is required.
Total of voting rights <3%

PART 4: PURCHASE POSITIONS PURSUANT TO ART. 14 PARA. 1 A FMIO-FINMA

Total of all purchase positions:
Total of all equity securities or equity related securities (item 1), number of voting rights that can be exercised at
one's own discretion (item 3) and derivative holdings (item 4)
Number of voting rights Percentage
S1 = [1.1] + [3.1] + [4.1] S2 = [1.2] + [3.2] + [4.2]
2,413,177 4.356%
===
Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index) or Publication according to art. 115 para. 3 FMIO:

55,400,000 1. Equity securities or equity related securities

===
Shares Number Voting rights1
Number Percentage2

Registered share 2,413,177 2,413,177      4.356% 
[1.1]       [1.2] 
Total           2,413,177      4.356% 1. Whether exercisable or not 2. Calculated on the basis of the total number of voting rights pursuant to the entry in the commercialregister (art. 14 para. 2 FMIO-FINMA) 2. Securities lending and comparable transactions in equity securities 

===
Of the equity securities mentioned in item 1 above, the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):

===
Agreed date of return transfer or, if there is a right to choose,

Nature of   whether this applies to the contracting party subject to the obligation 
Shares Number Proportion of         the                                                          to notify or to 
voting rights       legal                                                         the counterparty 

transaction 3. Voting rights that can be exercised at one's own discretion
===
The following voting rights were delegated by a third party and can be exercised at one's own discretion.

Voting rights

Is the person who has full discretionary powers to exercise voting rights directly or indirectly controlled?

Yes No 4. Derivative holdings

Conversion and share purchase rights (such as call-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) share sale rights and other derivative holdings:

===
Type of rights Number of rights Number of voting rights Security ID number (ISIN) if available or basic terms
conferred
Number Percentage2 Identity of issuer, subscription ratio, exercise
price,
exercise period, exercise type
===
[4.1] [4.2]

Total

2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA) 5. Securities lending and comparable transactions in derivative holdings

Of the derivative holdings mentioned in item 4 above, the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):

===
Agreed date of return transfer or, if there is a right to choose,

Number of                        whether this applies to the contracting party subject to the 
Nature of the  Number     reported  Proportion of                                            obligation to notify or to 
legal          of            voting voting rights                                                      the counterparty 
transaction    rights        rights PART 5: SALE POSITIONS PURSUANT TO ART. 14 PARA. 1 B FMIO-FINMA 

===
Total of all sale positions: Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index) or Publication according to art. 115 para. 3 FMIO:

55,400,000

Derivative holdings

Share sale rights (such as put-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) conversion and share purchase rights and other derivative holdings:

===
Type of rights Number of rights Number of voting rights Security ID number (ISIN) if available or basic terms
conferred
Number Percentage2 Identity of issuer, subscription ratio, exercise
price,
exercise period, exercise type
===
Total

2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)

-----------------------------------------------------------------------------------------------------------------------

2024-05-10 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      BB BIOTECH AG 

Schwertstrasse 6
8200 Schaffhausen
Switzerland
Internet: www.bbbiotech.ch

End of News EQS News Service
===
1900663 2024-05-10 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1900663&application_name=news

END) Dow Jones Newswires

May 10, 2024 11:40 ET (15:40 GMT)